Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine

09/26/2025

Dr. Feibi Zhang shares what patients need to know about surgery and thyroid cancer.

Dr. Feibi Zheng shares insights on thyroid issues and when surgery might be needed for thyroid conditions.

09/24/2025

Learn about leukemia, including the different types, causes and more. https://bit.ly/2XY3Z8u

09/15/2025

Learn about prostate cancer, including risk factors, symptoms and more. https://bit.ly/32iWbgY

09/12/2025

Dr. James Suliburk explains common signs, risk factors, treatments, and innovations on the horizon for thyroid cancer.

Dr. James Suliburk, chief of endocrine surgery at Baylor College of Medicine, explains common signs, risk factors and new treaments on the horizon for thyroid cancer.

09/10/2025

Dr. Edward Yen breaks down different prostate cancer treatment options.

“When we’re evaluating a case for treatment options, the first thing is to determine the stage,” Dr. Edward Yen, medical oncologist at Baylor College of Medicine in Houston, tells SurvivorNet.

09/08/2025

Gynecologic oncologists at the Dan L Duncan Comprehensive Cancer Center answer common questions about ovarian cancer risk factors and screening.

Gynecologic oncologists at the Dan L Duncan Comprehensive Cancer Center answer common questions about ovarian cancer risk factors and screening.

09/05/2025

Dr. Daniel Hamstra breaks down metastatic prostate cancer and what patients need to know about it.

At this stage, prostate cancer is generally not considered curable, but that doesn’t mean there’s no hope. In recent years, medical research has brought forward a range of new treatments that can slow down cancer growth, relieve symptoms, and extend survival — in some cases, for many years. Fo...

09/03/2025

September is Lymphoma Awareness Month. Learn about this disease, including symptoms, risk factors and more. https://bit.ly/3hRW5Bq

08/31/2025

The Dan L Duncan Comprehensive Cancer Center will be closed tomorrow, Monday, Sept. 1 in observance of Labor Day. We will reopen on Tuesday, Sept. 2.

08/29/2025

Researchers identified a biomarker in preclinical estrogen receptor-positive breast cancer models that indicates that the tumor is more likely to respond to treatment with CDK4/6 inhibitors.

A new study from researchers at Baylor College of Medicine brings hope for a more personalized approach to treat estrogen receptor-positive (ER+) breast...

08/27/2025

Learn about our current clinical trials. https://bit.ly/37C4AhS

08/25/2025

Dr. Hashem El-Serag spoke to the Broadcast Retirement Network about liver cancer and why cases are expected to double by 2050.

| Cases are Expected to by 2050 | Hashem El-Serag, Baylor College of Medicine | : broadcastretirementnet...